Cargando…

Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction

This paper proposes the design of combination opioid–adrenergic tethered compounds to enhance efficacy and specificity, lower dosage, increase duration of activity, decrease side effects, and reduce risk of developing tolerance and/or addiction. Combinations of adrenergic and opioid drugs are someti...

Descripción completa

Detalles Bibliográficos
Autor principal:	Root-Bernstein, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876737/ https://www.ncbi.nlm.nih.gov/pubmed/35215326 http://dx.doi.org/10.3390/ph15020214

Ejemplares similares

Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to “Biased Opioids”?
por: Root-Bernstein, Robert, et al.
Publicado: (2018)

Mutual Enhancement of Opioid and Adrenergic Receptors by Combinations of Opioids and Adrenergic Ligands Is Reflected in Molecular Complementarity of Ligands: Drug Development Possibilities
por: Root-Bernstein, Robert, et al.
Publicado: (2019)

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
por: Adhikari, Pramisha, et al.
Publicado: (2021)

Design and Synthesis of Conformationally Flexible Scaffold as Bitopic Ligands for Potent D(3)-Selective Antagonists
por: Kim, Ho Young, et al.
Publicado: (2022)

Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment
por: Gicquelais, Rachel E., et al.
Publicado: (2020)

Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors
por: Kudla, Lucja, et al.
Publicado: (2021)

Glutathione and Glutathione-Like Sequences of Opioid and Aminergic Receptors Bind Ascorbic Acid, Adrenergic and Opioid Drugs Mediating Antioxidant Function: Relevance for Anesthesia and Abuse
por: Root-Bernstein, Robert, et al.
Publicado: (2020)

Bitopic ligands: all-in-one orthosteric and allosteric
por: Kamal, Maud, et al.
Publicado: (2009)

Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy
por: Ramsell, Stuart, et al.
Publicado: (2022)

Correction: Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D(3) receptor agonists
por: Cao, Yongkai, et al.
Publicado: (2018)

QSPR analysis of some agonists and antagonists of α-adrenergic receptors
por: Kawczak, Piotr, et al.
Publicado: (2014)

Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities
por: Root-Bernstein, Robert, et al.
Publicado: (2021)

Bitopic Binding Mode of an M(1) Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes
por: Bradley, Sophie J., et al.
Publicado: (2018)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB(2) Receptor
por: Morales, Paula, et al.
Publicado: (2020)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Comparison of an Addictive Potential of μ-Opioid Receptor Agonists with G Protein Bias: Behavioral and Molecular Modeling Studies
por: Kudla, Lucja, et al.
Publicado: (2021)

Effects of Adrenergic Agonists and Antagonists on Cardiopulmonary Function During Normobaric Hypoxia in Rat
por: Bölter, Christian, et al.
Publicado: (2019)

Neural signatures of α2-Adrenergic agonist-induced unconsciousness and awakening by antagonist
por: Ballesteros, Jesus Javier, et al.
Publicado: (2020)

Simulations of Biased Agonists in the β(2) Adrenergic Receptor with Accelerated Molecular Dynamics
por: Tikhonova, Irina G., et al.
Publicado: (2013)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone
por: Støve, Svein Isungset, et al.
Publicado: (2022)

Characterization of β-adrenergic receptors in bovine intramuscular and subcutaneous adipose tissue: comparison of lubabegron fumarate with β-adrenergic receptor agonists and antagonists
por: Hwang, Jinhee H, et al.
Publicado: (2021)

The effect of two selective A(1)‐receptor agonists and the bitopic ligand VCP746 on heart rate and regional vascular conductance in conscious rats
por: Cooper, Samantha L., et al.
Publicado: (2020)

Synthesis of New Bitopic Tetra(pyrazolyl)-Ligands with Neopentane and O-Xylene Backbones
por: Potapov, Andrei S., et al.
Publicado: (2012)

The Role of Orthosteric Building Blocks of Bitopic Ligands for Muscarinic M1 Receptors
por: Volpato, Daniela, et al.
Publicado: (2020)

New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2
por: Ferrisi, Rebecca, et al.
Publicado: (2023)

Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management
por: Sadee, Wolfgang, et al.
Publicado: (2020)

Cocaine-Dosage and Cocaine-Addiction
por: Mattison, J. B.
Publicado: (1887)

Allosteric Antagonism of the A(2A) Adenosine Receptor by a Series of Bitopic Ligands
por: Gao, Zhan-Guo, et al.
Publicado: (2020)

Orthosteric and Allosteric Dual Targeting of the Nuclear Receptor RORγt with a Bitopic Ligand
por: Meijer, Femke A., et al.
Publicado: (2021)

Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021)

Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance
por: Mosberg, Henry I., et al.
Publicado: (2014)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

Effect Of α2-Adrenergic Agonists And Antagonists On Cytokine Release From Human Lung Macrophages Cultured In Vitro
por: Piazza, O., et al.
Publicado: (2016)

In Search of Synergistic Insect Repellents: Modeling of Muscarinic GPCR Interactions with Classical and Bitopic Photoactive Ligands
por: Niklas, Beata, et al.
Publicado: (2022)

Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis and FRET Investigation
por: Matera, Carlo, et al.
Publicado: (2023)

In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
por: Guillemyn, Karel, et al.
Publicado: (2012)

Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
por: Pani, Pier Paolo, et al.
Publicado: (2014)

β-Adrenergic Agonist and Antagonist Regulation of Autophagy in HepG2 Cells, Primary Mouse Hepatocytes, and Mouse Liver
por: Farah, Benjamin L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m10jh6n9c47naide88ipb3kh11